Published in Clin Exp Immunol on July 01, 1983
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
HLA and infectious diseases. Clin Microbiol Rev (2009) 2.35
Histometric study of the localisation of lymphocyte subsets and accessory cells in human Mantoux reactions. J Clin Pathol (1984) 2.25
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Leprosy. Clin Microbiol Rev (1988) 1.74
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63
Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55
Dynamics of T cells of L3T4 and Ly 2 phenotype within granulomas in murine listeriosis. Clin Exp Immunol (1985) 1.33
The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. J Exp Med (1989) 1.22
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol (1985) 1.13
Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest (1984) 1.11
Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. J Infect Dis (2010) 1.02
Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen. Proc Natl Acad Sci U S A (1993) 1.01
Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy. Clin Exp Immunol (1986) 0.93
Soluble serum interleukin 2 receptor levels in leprosy patients. Clin Exp Immunol (1987) 0.91
Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy. Clin Exp Immunol (1983) 0.87
Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy. BMJ Case Rep (2009) 0.85
Lymphocyte subpopulations in pyogranulomas of caseous lymphadenitis. Clin Exp Immunol (1991) 0.85
Phenotypic analysis of splenic lymphocytes and immunohistochemical study of hepatic granulomas after a murine infection with Salmonella abortusovis. Immunology (1991) 0.80
Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients. Immunology (2013) 0.79
Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses. Clin Exp Immunol (1989) 0.79
A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. Front Immunol (2017) 0.75
T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states. An Bras Dermatol (2015) 0.75
Immune reconstitution inflammatory syndrome unmasking erythema nodosum leprosum: a rare case report. Indian J Dermatol (2015) 0.75
Serum lymphocytotoxic activity in leprosy. Clin Exp Immunol (1989) 0.75
In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin. PLoS One (2017) 0.75
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
The differentiation and function of human T lymphocytes. Cell (1980) 11.88
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci U S A (1981) 3.62
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med (1982) 3.52
Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet (1966) 3.26
Histological classification and the immunological spectrum of leprosy. Bull World Health Organ (1974) 2.70
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol (1983) 2.01
T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies. Clin Exp Immunol (1983) 1.93
Studies on T cell subsets and functions in leprosy. Clin Exp Immunol (1981) 1.22
The histological course of reactions in borderline leprosy and their outcome. Int J Lepr Other Mycobact Dis (1981) 1.04
Lucio's phenomenon: a comparative histological study. Int J Lepr Other Mycobact Dis (1979) 1.04
Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy. Int J Lepr Other Mycobact Dis (1980) 1.04
Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies. Int J Lepr Other Mycobact Dis (1982) 0.98
REACTION OF THE DERMIS IN LEPROSY. Int J Lepr (1964) 0.97
Erythema nodosum leprosum in a general hospital. Arch Dermatol (1975) 0.96
Hypothesis: erythema nodosum leprosum is precipitated by an imbalance of T lymphocytes. Lepr Rev (1982) 0.94
Defect in the generation of cytotoxic T cells in lepromatous leprosy. Clin Exp Immunol (1982) 0.92
Serum macrophage migration inhibition activity in patients with leprosy. J Invest Dermatol (1982) 0.86
Erythema nodosum in leprosy. J Chronic Dis (1963) 0.83
In situ characterization of T lymphocyte subsets in leprosy granulomas. Int J Lepr Other Mycobact Dis (1982) 0.83
Lucio's phenomenon: an immune complex deposition syndrome in lepromatous leprosy. Clin Immunol Immunopathol (1978) 0.82
The histology of erythema nodosum leprosum. Variant forms in New Guineans and other ethnic groups. Lepr Rev (1981) 0.80
Lucio's phenomenon and diffuse nonnodular lepromatous leprosy. Arch Dermatol (1978) 0.80
Significance of neutrophil activation in reactional lepromatous leprosy: effects of thalidomide in vivo and in vitro. Activation in adjuvant disease. Int Arch Allergy Appl Immunol (1978) 0.80
Erythema nodosum leprosum. Arch Dermatol (1977) 0.79
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Mechanical work in terrestrial locomotion: two basic mechanisms for minimizing energy expenditure. Am J Physiol (1977) 4.79
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol (1999) 4.10
The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol (1975) 4.03
Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85
Muscular force in running turkeys: the economy of minimizing work. Science (1997) 3.45
Immunoperoxidase techniques: practical and theoretical aspects. Arch Pathol Lab Med (1978) 3.42
The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody. J Clin Pathol (1974) 3.41
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23
Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest (1993) 3.15
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Energetics of running: a new perspective. Nature (1990) 2.96
Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51
Intracellular immunoglobulins. A comparative study on three standard tissue processing methods using horseradish peroxidase and fluorochrome conjugates. J Clin Pathol (1974) 2.36
Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27
Energetics and mechanics of terrestrial locomotion. I. Metabolic energy consumption as a function of speed and body size in birds and mammals. J Exp Biol (1982) 2.25
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13
Antigen retrieval techniques: current perspectives. J Histochem Cytochem (2001) 2.11
Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst (1998) 2.07
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med (1999) 2.06
The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 2.04
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01
T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol (1983) 2.01
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol (1999) 1.96
Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem (1997) 1.96
Analysis of fluorescence decay curves by means of the Laplace transformation. Biophys J (1975) 1.96
The nature of Reed-Sternberg cells and other malignant "reticulum" cells. Lancet (1974) 1.95
Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem (1993) 1.91
A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol (2000) 1.90
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Wood's light in dermatology. Int J Dermatol (1999) 1.84
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
The concept of symmorphosis: a testable hypothesis of structure-function relationship. Proc Natl Acad Sci U S A (1991) 1.80
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease. Eur J Cancer (1976) 1.78
Gamma delta T lymphocytes in human tuberculosis. J Infect Dis (1992) 1.78
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
The immunohistological detection of intracellular immunoglobulin in formalin-paraffin sections from multiple myeloma and related conditions using the immunoperoxidase technique. Clin Exp Immunol (1974) 1.76
Design of the mammalian respiratory system. III Scaling maximum aerobic capacity to body mass: wild and domestic mammals. Respir Physiol (1981) 1.74
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol (1997) 1.73
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
Speed, stride frequency and energy cost per stride: how do they change with body size and gait? J Exp Biol (1988) 1.69
Energetics and mechanics of terrestrial locomotion. III. Energy changes of the centre of mass as a function of speed and body size in birds and mammals. J Exp Biol (1982) 1.69
Design of the mammalian respiratory system. I. Problem and strategy. Respir Physiol (1981) 1.67
Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am J Pathol (1982) 1.66
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65
Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res (1998) 1.65
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65
Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A (1988) 1.62
Molecular interaction of CD1b with lipoglycan antigens. Immunity (1998) 1.60
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature (1986) 1.56
Tumor necrosis factor production in patients with leprosy. Infect Immun (1992) 1.55
Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55
The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med (2000) 1.54
Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol (1978) 1.54
308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol (2000) 1.54
Isolation and characterization of the highly immunogenic cell wall-associated protein of Mycobacterium leprae. J Immunol (1989) 1.54
Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol (1992) 1.52
A predominance of the T cell receptor V gamma 2/V delta 2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J Immunol (1991) 1.52
Stigma variations: observations on suppressor T cells and leprosy. Annu Rev Immunol (1992) 1.51
Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am J Pathol (1983) 1.51
Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol (2000) 1.50
Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem (1995) 1.50